Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD

PURPOSE: Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic (dysfunction) associated fatty liver disease (MAFLD), is the most common chronic liver disease in the United States. Presently, there is an intense and ongoing effort to identify and develop novel therapeutics for this di...

Descripción completa

Detalles Bibliográficos
Autores principales: McCall, Kelly D, Walter, Debra, Patton, Ashley, Thuma, Jean R, Courreges, Maria C, Palczewski, Grzegorz, Goetz, Douglas J, Bergmeier, Stephen, Schwartz, Frank L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658948/
https://www.ncbi.nlm.nih.gov/pubmed/38026235
http://dx.doi.org/10.2147/JIR.S413565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658948/
https://www.ncbi.nlm.nih.gov/pubmed/38026235
http://dx.doi.org/10.2147/JIR.S413565

Ejemplares similares